Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Mealworm protein helps fat cell development and may aid in metabolic health and hair growth.

Feminizing hormone therapy increases hair counts and improves hair-related quality of life, while masculinizing therapy may reduce large terminal hairs.

Transgender patients face more barriers to oral healthcare, leading to poorer oral health and quality of life.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Belimumab may cause hair loss in lupus patients.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

The hair tonic made from oil palm leaf extract is very effective in preventing hair damage from the sun.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

IFHUT shows better hair growth than FUE, but needs improvements in positioning, speed, and accuracy.

HFMs can help study hair growth and test potential hair growth drugs.

Hepatitis C treatment may cause frontal fibrosing alopecia.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

The document's conclusion cannot be provided because the content is not available.

Follicular unit hair transplantation is the standard method for natural-looking hair restoration in androgenic alopecia.

High-frequency ultrasound effectively evaluates and diagnoses frontal fibrosing alopecia.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

The fuzzy gene is crucial for controlling hair growth cycles.

High-frequency ultrasonography helps diagnose and manage hair and nail disorders safely and effectively.

A genetic marker linked to a type of hair loss was found in most patients studied.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Overexpressing the human H-ferritin gene in mice causes mild growth delay and temporary hair loss.

A patient with hair loss condition grew excessive hair in areas covered by a cast.

FFA can be mistaken for rosacea, requiring specific treatment for accurate diagnosis and management.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

Certain genetic factors may contribute to frontal fibrosing alopecia in Brazil.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.